(E) -5-Hydroxyferulic acid

CAT:
804-HY-133068A
Size:
1 Each
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
(E) -5-Hydroxyferulic acid - image 1

(E) -5-Hydroxyferulic acid

  • Description:

    (E) -5-Hydroxyferulic acid is the E-isomer of 5-Hydroxyferulic acid (HY-133068) . 5-hydroxyferulic acid is a hydroxycinnamic acid and is a metabolite of the phenylpropanoid pathway. 5-Hydroxyferulic acid is a precursor in the biosynthesis of sinapic acid and is also a COMT non-esterifed substrat[1][2][3].
  • UNSPSC:

    12352005
  • Hazard Statement:

    H315, H319, H335
  • Target:

    COMT
  • Type:

    Reference compound
  • Related Pathways:

    Metabolic Enzyme/Protease; Neuronal Signaling
  • Applications:

    Metabolism-sugar/lipid metabolism
  • Field of Research:

    Metabolic Disease
  • Assay Protocol:

    https://www.medchemexpress.com/e-5-hydroxyferulic-acid.html
  • Solubility:

    10 mM in DMSO
  • Smiles:

    O=C (O) /C=C/C1=CC (OC) =C (O) C (O) =C1
  • Molecular Formula:

    C10H10O5
  • Molecular Weight:

    210.19
  • Precautions:

    H315, H319, H335
  • References & Citations:

    [1]Parvathi K, et al. Substrate preferences of O-methyltransferases in alfalfa suggest new pathways for 3-O-methylation of monolignols. Plant J. 2001 Jan;25 (2) :193-202.|[2]Maury S, et al. Tobacco O-methyltransferases involved in phenylpropanoid metabolism. The different caffeoyl-coenzyme A/5-hydroxyferuloyl-coenzyme A 3/5-O-methyltransferase and caffeic acid/5-hydroxyferulic acid 3/5-O-methyltransferase classes have distinct substrate specificities and expression patterns. Plant Physiol. 1999 Sep;121 (1) :215-24.|[3]Inoue K, et al. Substrate preferences of caffeic acid/5-hydroxyferulic acid 3/5-O-methyltransferases in developing stems of alfalfa (Medicago sativa L.) . Arch Biochem Biophys. 2000 Mar 1;375 (1) :175-82.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, stored under nitrogen)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    No Development Reported
  • CAS Number:

    110642-42-7